Recognise that patients presenting to you unwell, may be so as a result of an adverse reaction these medications; be aware of important adverse effects and interactions to avoid in inadvertent serious drug-drug interactions
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
-
Gastroenterology and Cancer (MET3A) (Year 3)
- SDL & CE: Pharmacological Management of Inflammatory Bowel Disease (Priority 2)
Assessment
This learning outcome is assessed in the following ways:
- NOT YET CATEGORISED
